Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant ... By 1910, there were over 700 new products in the Abbott catalogue. The company had expanded ...

The Department of Justice announced an investigation into Abbott Laboratories' Michigan plant ... several of its ready-to-feed baby formula products due to a bottle defect that could result ...

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...

Adam Maeder, an analyst from Piper Sandler, has initiated a new Buy rating on Abbott Laboratories (ABT). Adam Maeder has given his Buy rating ...

Abbott Laboratories (ABT) stock saw a decline, ending the day at $114.88 which represents a decrease of $-3.25 or -2.75% from the prior close of $118.13. The stock opened at $117.5 and touched a low ...

Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

A total of 94 to 95% of the label claim amount of clarithromycin from the reference product (Abbott Laboratories) dissolved in 30 minutes. It is interesting to note that while most of the generic ...

Shares of Abbott Laboratories ABT sank 0.37% to $116.40 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.54% to 5,626.02 ...

Fintel reports that on September 19, 2024, Piper Sandler initiated coverage of Abbott Laboratories ( LSE:0Q15) with a Overweight recommendation. What is the Fund Sentiment?

However, sales of these products started declining as the outbreak receded, leading to more uneven revenue growth for the company. Throughout it all, one of Abbott Laboratories' segments has been ...